Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: Development of FTIR Fingerprint Spectrum – V 2.0

Posted on By

Analytical Method Development: Development of FTIR Fingerprint Spectrum – V 2.0

SOP for Development of FTIR Fingerprint Spectrum for Pharmaceutical Substances


Department Analytical Method Development
SOP No. SOP/AMD/096/2025
Supersedes SOP/AMD/096/2022
Page No. Page 1 of 14
Issue Date 19/05/2025
Effective Date 20/05/2025
Review Date 19/05/2026

1. Purpose

This SOP describes the standardized procedure for developing a fingerprint region spectrum using Fourier Transform Infrared (FTIR) Spectroscopy to characterize Active Pharmaceutical Ingredients (APIs) and compare them with reference standards for

identity confirmation.

2. Scope

This procedure applies to the Analytical Method Development (AMD) laboratory and covers FTIR spectrum generation of pure APIs, intermediates, and excipients using potassium bromide (KBr) pellet or ATR techniques.

3. Responsibilities

  • Analytical Chemist: Prepares the sample and collects the FTIR spectrum.
  • Reviewer: Compares spectra with reference standards and interprets functional group regions.
  • QA Officer: Verifies documentation for compliance with ICH and pharmacopeial requirements.
  • Head – AMD: Reviews and approves final spectral data and interpretation reports.

4. Accountability

The Head of Analytical Method Development is accountable for ensuring the FTIR fingerprint spectrum is scientifically valid and compliant with GMP, ICH Q2(R1), and regulatory expectations for identity confirmation.

See also  Analytical Method Development: SOP for Flow Property Evaluation of Powders - V 2.0

5. Procedure

5.1 Instrument Calibration

  1. Ensure FTIR spectrometer is qualified and calibrated as per internal procedures.
  2. Verify wavelength accuracy using polystyrene film; confirm peaks at ~1601 cm-1 and ~1154 cm-1.
  3. Document calibration check in Annexure-1: Instrument Calibration Record.

5.2 Sample Preparation

  1. KBr Pellet Method:
    • Dry KBr (IR grade) at 105°C for at least 2 hours before use.
    • Grind 1-2 mg of API with ~200 mg KBr in a mortar and pestle until uniform.
    • Compress into a transparent pellet using a hydraulic press.
  2. ATR Method (if applicable):
    • Place a small amount of dry API powder directly on the ATR crystal.
    • Apply uniform pressure using the pressure arm for good contact.
  3. Document preparation method in Annexure-2: Sample Preparation Log.

5.3 Background Collection

  1. Run a background scan using dry KBr pellet or empty ATR crystal.
  2. Ensure the background is collected immediately before sample scan to eliminate atmospheric CO2 and H2O interference.
  3. Record scan parameters in Annexure-3: Background Log.

5.4 Sample Spectrum Collection

  1. Collect the spectrum in transmittance mode from 4000 to 400 cm-1.
  2. Set resolution to 4 cm-1, with 32–64 scans per sample for adequate signal-to-noise ratio.
  3. Record absorbance peaks and baseline quality.
  4. Save spectrum file and export as PDF or ASCII format.
  5. Print spectrum and paste in Annexure-4: Sample Spectrum Record.
See also  Analytical Method Development: Preparation of Calibration Curve in UV - V 2.0

5.5 Interpretation of Fingerprint Region

  1. Focus on region from 1800 to 600 cm-1 for fingerprint identification.
  2. Compare peak position, shape, and intensity with that of reference standard.
  3. Functional group region (4000–1800 cm-1) may be used to support interpretation.
  4. Confirm presence of key peaks such as:
    • C=O: ~1700 cm-1
    • OH (broad): ~3200–3500 cm-1
    • CH stretch: ~2800–3000 cm-1
  5. Record interpretation in Annexure-5: Peak Assignment Sheet.

5.6 Comparison with Reference Standard

  1. Overlay test and reference spectra using instrument software.
  2. Acceptance criteria: spectra should be concordant with reference spectrum with no additional or missing peaks in fingerprint region.
  3. Document overlay and conclusion in Annexure-6: Spectrum Comparison Sheet.

5.7 Precautions

  1. Ensure all samples and KBr are moisture-free to prevent O-H stretching interference.
  2. Clean ATR crystal thoroughly before and after use to prevent cross-contamination.
  3. Use desiccators for storing KBr and prepared pellets.

6. Abbreviations

  • FTIR: Fourier Transform Infrared Spectroscopy
  • ATR: Attenuated Total Reflectance
  • API: Active Pharmaceutical Ingredient
  • KBr: Potassium Bromide
  • SOP: Standard Operating Procedure
  • cm-1: Wavenumber (reciprocal centimeters)

7. Documents

  1. Instrument Calibration Record – Annexure-1
  2. Sample Preparation Log – Annexure-2
  3. Background Log – Annexure-3
  4. Sample Spectrum Record – Annexure-4
  5. Peak Assignment Sheet – Annexure-5
  6. Spectrum Comparison Sheet – Annexure-6
See also  Analytical Method Development: Literature Review for Method Development - V 2.0

8. References

  • ICH Q2(R1) – Validation of Analytical Procedures
  • USP <197K> – Infrared Spectrophotometry
  • Pharmaceutical Infrared Spectroscopy Texts
  • FTIR Instrument Manufacturer’s Manual

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Instrument Calibration Record

Date Standard Used Wavelengths Observed (cm-1) Status
19/05/2025 Polystyrene Film 1601, 1154 Pass

Annexure-2: Sample Preparation Log

Sample ID Method KBr Quantity (mg) API Weight (mg) Remarks
API-FTIR-096 KBr Pellet 200 1.5 Uniform Mix

Annexure-3: Background Log

Date Mode Solvent/KBr Used Status
19/05/2025 Transmittance Dry KBr Clear

Annexure-4: Sample Spectrum Record

Attach printed FTIR spectrum here along with file name, scan parameters, and analyst initials.

Annexure-5: Peak Assignment Sheet

Peak Position (cm-1) Functional Group Interpretation
1702 C=O Stretch Present
2955 CH Stretch Alkane

Annexure-6: Spectrum Comparison Sheet

Sample Reference Overlay Match (%) Conclusion
API-FTIR-096 Reference-096 98.9% Match

Revision History:

Revision Date Revision No. Details Reason Approved By
04/05/2025 2.0 Enhanced interpretation section and expanded annexure fields Annual SOP Review
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Aerosol: SOP for Vendor Qualification for Aerosol Components – V 2.0
Next Post: Gel Manufacturing: SOP for Cleaning Filling Machines Post Gel Filling – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version